Sanofi SA Given Consensus Rating of “Hold” by Analysts (NYSE:SNY)
Sanofi SA (NYSE:SNY) has earned an average rating of “Hold” from the ten ratings firms that are presently covering the stock, Analyst RN reports. Six research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $54.50.
A number of analysts have recently weighed in on SNY shares. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi SA in a research note on Monday. They now have a $56.00 price target on the stock. Analysts at Mainfirst upgraded shares of Sanofi SA to an “outperform” rating in a research note on Monday, July 28th.
Shares of Sanofi SA (NYSE:SNY) opened at 51.43 on Monday. Sanofi SA has a 52 week low of $46.95 and a 52 week high of $54.64. The stock’s 50-day moving average is $52.50 and its 200-day moving average is $51.96. The company has a market cap of $135.0 billion and a P/E ratio of 25.15.
Sanofi SA (NYSE:SNY) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.72 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.79 by $0.07. Analysts expect that Sanofi SA will post $3.50 EPS for the current fiscal year.
Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.
Receive News & Ratings for Sanofi SA (ADR) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi SA (ADR) and related companies with Analyst Ratings Network's FREE daily email newsletter.